Home › Companies › curacle

curacle

큐라클 · 365270 · KOSDAQ
Filings, last 12 months
27
Supply contracts
0
Insider reports
6
Share & bond issues
0

At a glance

curacle filed 27 disclosures in the last 12 months, including 6 insider. The most recent key filing was on Jun 10.

Revenue for 2025 was ₩7.1M, down 99.6% on 2024. It made an operating loss of ₩16.5B. Debt was 43% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩8.2B and operating loss of ₩640.7M.

The 2025 annual report lists 31 employees with an average tenure of 4.2 years and average pay of ₩81.9M. Its 7 directors and auditors were paid ₩240M each on average. It paid no cash dividend for 2025. 권영근 and related parties held 8.93% at year end.

From the 2025 annual report

Employees
31
Average pay
₩81.9M
Average tenure
4.2 yrs
Avg. director pay
₩240M

Staff: 31 (17 men, 14 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩2.6B. Directors and auditors: 7, paid ₩858M in total.

No cash dividend was paid for 2025.

Largest shareholder

권영근 holds 8.62%; with 2 related parties the group holds 8.93% of common shares at year end (from 13.33% at the start of the year).

Auditor: 다산회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

2023
Revenue ₩10.3B
Op. profit -₩10.5B
Debt/equity 67%
2024
Revenue ₩1.6B
Op. profit -₩12.6B
Debt/equity 98%
2025
Revenue ₩7.1M
Op. profit -₩16.5B
Debt/equity 43%
2026 H1
Revenue ₩8.2B
Op. profit -₩640.7M
Debt/equity 27%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

Key filings

Other filings

Links open the original filing on DART, in Korean.